NO20064352L - Fremgangsmate for fremstilling av pyrrolidinoksimer - Google Patents
Fremgangsmate for fremstilling av pyrrolidinoksimerInfo
- Publication number
- NO20064352L NO20064352L NO20064352A NO20064352A NO20064352L NO 20064352 L NO20064352 L NO 20064352L NO 20064352 A NO20064352 A NO 20064352A NO 20064352 A NO20064352 A NO 20064352A NO 20064352 L NO20064352 L NO 20064352L
- Authority
- NO
- Norway
- Prior art keywords
- oxymers
- pyrrolidine
- preparation
- formula
- dysmenorrhea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pregnancy & Childbirth (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04100773 | 2004-02-26 | ||
| PCT/EP2005/050852 WO2005082848A2 (en) | 2004-02-26 | 2005-02-28 | Method for preparing pyrrolidine oximes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20064352L true NO20064352L (no) | 2006-09-26 |
Family
ID=34896105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20064352A NO20064352L (no) | 2004-02-26 | 2006-09-26 | Fremgangsmate for fremstilling av pyrrolidinoksimer |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20070197794A1 (de) |
| EP (1) | EP1725526B1 (de) |
| JP (1) | JP2007524702A (de) |
| KR (1) | KR20060124775A (de) |
| CN (1) | CN1946686A (de) |
| AT (1) | ATE380792T1 (de) |
| AU (1) | AU2005217153A1 (de) |
| BR (1) | BRPI0508059A (de) |
| CA (1) | CA2554767A1 (de) |
| CY (1) | CY1107139T1 (de) |
| DE (1) | DE602005003803T2 (de) |
| DK (1) | DK1725526T3 (de) |
| EA (1) | EA011026B1 (de) |
| ES (1) | ES2296137T3 (de) |
| IL (1) | IL177388A0 (de) |
| NO (1) | NO20064352L (de) |
| PL (1) | PL1725526T3 (de) |
| PT (1) | PT1725526E (de) |
| SI (1) | SI1725526T1 (de) |
| UA (1) | UA86226C2 (de) |
| WO (1) | WO2005082848A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2845850A1 (de) | 2013-09-10 | 2015-03-11 | ObsEva S.A. | Pyrrolidinderivate als Oxytocin/Vasopressin-V1a-Rezeptorantagonisten |
| EP2886107A1 (de) | 2013-12-17 | 2015-06-24 | ObsEva S.A. | Orale Formulierungen von Pyrrolydinderivaten |
| AU2015283133B2 (en) | 2014-07-02 | 2019-05-16 | ObsEva SA | Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime useful in methods of treating conditions related to the OT-R activity |
| WO2021165927A1 (en) * | 2020-02-21 | 2021-08-26 | Wockhardt Bio Ag | 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6329418B1 (en) * | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
| HRP20020705A2 (en) * | 2000-03-27 | 2004-12-31 | Applied Research Systems | Pharmaceutically active pyrrolidine derivatives |
| BR0211030A (pt) * | 2001-06-18 | 2004-06-22 | Applied Research Systems | Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole |
-
2005
- 2005-02-28 DE DE602005003803T patent/DE602005003803T2/de not_active Expired - Fee Related
- 2005-02-28 CA CA002554767A patent/CA2554767A1/en not_active Abandoned
- 2005-02-28 AT AT05708062T patent/ATE380792T1/de not_active IP Right Cessation
- 2005-02-28 US US10/590,813 patent/US20070197794A1/en not_active Abandoned
- 2005-02-28 DK DK05708062T patent/DK1725526T3/da active
- 2005-02-28 BR BRPI0508059-2A patent/BRPI0508059A/pt not_active IP Right Cessation
- 2005-02-28 KR KR1020067019448A patent/KR20060124775A/ko not_active Withdrawn
- 2005-02-28 EA EA200601456A patent/EA011026B1/ru not_active IP Right Cessation
- 2005-02-28 WO PCT/EP2005/050852 patent/WO2005082848A2/en not_active Ceased
- 2005-02-28 EP EP05708062A patent/EP1725526B1/de not_active Expired - Lifetime
- 2005-02-28 SI SI200530122T patent/SI1725526T1/sl unknown
- 2005-02-28 AU AU2005217153A patent/AU2005217153A1/en not_active Abandoned
- 2005-02-28 JP JP2007500229A patent/JP2007524702A/ja active Pending
- 2005-02-28 PL PL05708062T patent/PL1725526T3/pl unknown
- 2005-02-28 PT PT05708062T patent/PT1725526E/pt unknown
- 2005-02-28 ES ES05708062T patent/ES2296137T3/es not_active Expired - Lifetime
- 2005-02-28 CN CNA200580012856XA patent/CN1946686A/zh active Pending
- 2005-02-28 UA UAA200609783A patent/UA86226C2/uk unknown
-
2006
- 2006-08-09 IL IL177388A patent/IL177388A0/en unknown
- 2006-09-26 NO NO20064352A patent/NO20064352L/no not_active Application Discontinuation
-
2008
- 2008-01-14 CY CY20081100051T patent/CY1107139T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1946686A (zh) | 2007-04-11 |
| JP2007524702A (ja) | 2007-08-30 |
| KR20060124775A (ko) | 2006-12-05 |
| DE602005003803T2 (de) | 2008-12-24 |
| EP1725526B1 (de) | 2007-12-12 |
| PL1725526T3 (pl) | 2008-03-31 |
| ES2296137T3 (es) | 2008-04-16 |
| US20070197794A1 (en) | 2007-08-23 |
| SI1725526T1 (sl) | 2008-04-30 |
| DK1725526T3 (da) | 2008-03-03 |
| WO2005082848A2 (en) | 2005-09-09 |
| IL177388A0 (en) | 2006-12-10 |
| CY1107139T1 (el) | 2012-10-24 |
| AU2005217153A1 (en) | 2005-09-09 |
| UA86226C2 (en) | 2009-04-10 |
| DE602005003803D1 (de) | 2008-01-24 |
| WO2005082848A3 (en) | 2005-12-01 |
| BRPI0508059A (pt) | 2007-07-17 |
| ATE380792T1 (de) | 2007-12-15 |
| EP1725526A2 (de) | 2006-11-29 |
| EA011026B1 (ru) | 2008-12-30 |
| PT1725526E (pt) | 2007-12-27 |
| EA200601456A1 (ru) | 2007-02-27 |
| CA2554767A1 (en) | 2005-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
| TW200800997A (en) | Chemical compounds | |
| DE602005019078D1 (de) | Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| UA96971C2 (ru) | Способ получения фторметилзамещенных гетероциклических соединений | |
| NO20053890L (no) | Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner | |
| CY1111327T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος | |
| SE0401762D0 (sv) | Novel compounds | |
| ATE457310T1 (de) | Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE602004020734D1 (de) | Derivate von piperazine-2-carboxamide | |
| DE602006010433D1 (de) | Für die behandlung von obesitas geeignete tricyclische amidderivate | |
| ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
| PL1758852T3 (pl) | Podstawione związki cyklopentenu | |
| CY1107139T1 (el) | Μεθοδος παρασκευης πυρρολιδινοξιμων | |
| NO20055750L (no) | Nye kjemiske forbindelser | |
| DK1745010T3 (da) | Substituerede cyklohexyl-1,4-diaminderivater | |
| TW200635905A (en) | Processes for producing 4-aminoquinazolines | |
| ATE407126T1 (de) | Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on | |
| NO20050980L (no) | Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider | |
| ATE538109T1 (de) | Neue für die behandlung von obesitas und diabetes geeignete 2-(2-hydroxyphenyl)benzothiadiazine | |
| MX2008000821A (es) | Nuevos derivados de piperidina. | |
| ATE473213T1 (de) | Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
| TW200621713A (en) | Process for the preparation of n-aminopiperidine and its salts | |
| TW200626525A (en) | Synthesis of polyamine compounds | |
| MXPA06000995A (es) | Amidas novedosas de acido indolil-3-glioxilico sustituidas en el atomo de n, uso de las mismas como medicamento y metodo para la produccion de las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |